Skip to main content
. 2016 Apr 5;39(6):1027–1035. doi: 10.2337/dc15-1136

Figure 2.

Figure 2

Change in glucagon concentrations after meal challenge before and after 12 weeks of liraglutide or placebo treatments (A) and AUC for glucagon change at 12 weeks compared with 0 weeks in all groups (B) in patients with T1D. *P < 0.05 compared with 0 weeks. Change in glucose concentrations after meal challenge before and after 12 weeks of liraglutide or placebo treatments (C) and AUC for glucose change at 12 weeks (W) compared with 0 weeks in all groups (D) in patients with T1D. *P < 0.05 compared with 0 weeks. hr, hours; PP, postprandial.